Pasinetti GM - Search Results

1

Shared genetic etiology underlying Alzheimer's disease and type 2 diabetes.

Hao K, Di Narzo AF, Ho L, Luo W, Li S, Chen R, Li T, Dubner L, Pasinetti GM. Hao K, et al. Among authors: pasinetti gm. Mol Aspects Med. 2015 Jun-Oct;43-44:66-76. doi: 10.1016/j.mam.2015.06.006. Epub 2015 Jun 23. Mol Aspects Med. 2015. PMID: 26116273 Free PMC article. Review.

2

Induction of cyclooxygenase (COX)-2 but not COX-1 gene expression in apoptotic cell death.

Ho L, Osaka H, Aisen PS, Pasinetti GM. Ho L, et al. Among authors: pasinetti gm. J Neuroimmunol. 1998 Aug 14;89(1-2):142-9. doi: 10.1016/s0165-5728(98)00132-5. J Neuroimmunol. 1998. PMID: 9726836

3

Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease.

Ho L, Pieroni C, Winger D, Purohit DP, Aisen PS, Pasinetti GM. Ho L, et al. Among authors: pasinetti gm. J Neurosci Res. 1999 Aug 1;57(3):295-303. doi: 10.1002/(SICI)1097-4547(19990801)57:3<295::AID-JNR1>3.0.CO;2-0. J Neurosci Res. 1999. PMID: 10412020

4

Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia.

Luterman JD, Haroutunian V, Yemul S, Ho L, Purohit D, Aisen PS, Mohs R, Pasinetti GM. Luterman JD, et al. Among authors: pasinetti gm. Arch Neurol. 2000 Aug;57(8):1153-60. doi: 10.1001/archneur.57.8.1153. Arch Neurol. 2000. PMID: 10927795

5

Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique.

Ho L, Guo Y, Spielman L, Petrescu O, Haroutunian V, Purohit D, Czernik A, Yemul S, Aisen PS, Mohs R, Pasinetti GM. Ho L, et al. Among authors: pasinetti gm. Neurosci Lett. 2001 Feb 9;298(3):191-4. doi: 10.1016/s0304-3940(00)01753-5. Neurosci Lett. 2001. PMID: 11165439

6

Elevated plasma neopterin levels in Alzheimer disease.

Hull M, Pasinetti GM, Aisen PS. Hull M, et al. Among authors: pasinetti gm. Alzheimer Dis Assoc Disord. 2000 Oct-Dec;14(4):228-30. doi: 10.1097/00002093-200010000-00007. Alzheimer Dis Assoc Disord. 2000. PMID: 11186601

7

Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease.

Ho L, Purohit D, Haroutunian V, Luterman JD, Willis F, Naslund J, Buxbaum JD, Mohs RC, Aisen PS, Pasinetti GM. Ho L, et al. Among authors: pasinetti gm. Arch Neurol. 2001 Mar;58(3):487-92. doi: 10.1001/archneur.58.3.487. Arch Neurol. 2001. PMID: 11255454

8

Gene expression profiling of the tau mutant (P301L) transgenic mouse brain.

Ho L, Xiang Z, Mukherjee P, Zhang W, De Jesus N, Mirjany M, Yemul S, Pasinetti GM. Ho L, et al. Among authors: pasinetti gm. Neurosci Lett. 2001 Sep 7;310(1):1-4. doi: 10.1016/s0304-3940(01)02044-4. Neurosci Lett. 2001. PMID: 11524143

9

Induction of the complement component C1qB in brain of transgenic mice with neuronal overexpression of human cyclooxygenase-2.

Spielman L, Winger D, Ho L, Aisen PS, Shohami E, Pasinetti GM. Spielman L, et al. Among authors: pasinetti gm. Acta Neuropathol. 2002 Feb;103(2):157-62. doi: 10.1007/s004010100447. Epub 2001 Nov 24. Acta Neuropathol. 2002. PMID: 11810182

10

From cDNA microarrays to high-throughput proteomics. Implications in the search for preventive initiatives to slow the clinical progression of Alzheimer's disease dementia.

Pasinetti GM, Ho L. Pasinetti GM, et al. Restor Neurol Neurosci. 2001;18(2-3):137-42. Restor Neurol Neurosci. 2001. PMID: 11847436 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

299 results

Search Page